Universal CAR-T cell therapy targeting CD19 and BCMA

CAR-T cell therapy targeting CD19 and BCMA · Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Universal CAR-T cell therapy targeting CD19 and BCMA, covering 2025-12-30 to 2025-12-30. Get the full timeline:

Most recent: Clinical Trial Update: Universal CAR-T Cell Injection Targeting CD19/BCMA in Patients With Inflammatory Bowel Disease [EARLY_Phase 1]

See pricing